You are here

CIDP

Argenx' Vyvgart launch in CIDP picks up as the company barrels toward 10 indications by 2030

Fierce Pharma

Sun, 11/3/24 - 10:13 pm

FDA starts review of Argenx drug in rare disease CIDP

Pharmaphorum

Tue, 02/20/24 - 11:01 am

Vyvgart shines in CIDP study, teeing up another potential nod for Argenx's pipeline in a product

Fierce Pharma

Tue, 07/18/23 - 10:29 am

clinical trials